Acular LS Related Published Studies
Well-designed clinical trials related to Acular LS (Ketorolac Ophthalmic)
Topical bromfenac 0.09% vs. ketorolac 0.4% for the control of pain, photophobia, and discomfort following PRK. [2009.02]
Acular LS before and during LASIK for the control of pain: a randomized, masked contralateral eye trial. [2009.02]
A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients. [2008.10]
Topical ketorolac in vitreoretinal surgery: a prospective, randomized, placebo-controlled, double-masked trial. [2008.09]
Comparison of ketorolac 0.4% and bromfenac 0.09% at trough dosing: aqueous drug absorption and prostaglandin E2 levels. [2008.09]
Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. [2008.01]
Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial. [2007.11]
In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac. [2007.09]
Prostaglandin E2 inhibition and aqueous concentration of ketorolac 0.4% (acular LS) and nepafenac 0.1% (nevanac) in patients undergoing phacoemulsification. [2007.07]
Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve. [2006.09]
Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation. [2006.08]
The effects of topical ketorolac and indomethacin on measles conjunctivitis: randomized controlled trial. [2006.05]
Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study. [2005.08]
A randomised, double-blind trial of topical ketorolac vs artificial tears for the treatment of episcleritis. [2005.07]
Well-designed clinical trials possibly related to Acular LS (Ketorolac Ophthalmic)
Desflurane versus sevoflurane for maintenance of outpatient anesthesia: the effect on early versus late recovery and perioperative coughing. [2009.08]
Comparison of topical lignocaine gel and fentanyl for perioperative analgesia in children undergoing cataract surgery. [2009.04]
Other research related to Acular LS (Ketorolac Ophthalmic)
Aqueous prostaglandin E(2) of cataract patients at trough ketorolac and bromfenac levels after 2 days dosing. [2009.06]
Pseudophakic macular edema and oral acetazolamide: an optical coherence tomography measurable, dose-related response. [2008.11]
A Randomized, Masked Comparison of Topical Ketorolac 0.4% Plus Steroid vs Steroid Alone in Low-Risk Cataract Surgery Patients. [2008.07.01]
Ketorolac tromethamine 0.4% as a treatment for allergic conjuctivitis. [2008.04]
Impaired corneal wound healing associated with ketorolac 0.5% after uncomplicated extracapsular cataract extraction. [2007.12]
Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation. [2007.07]
Double-masked study of the effects of nepafenac 0.1% and ketorolac 0.4% on corneal epithelial wound healing and pain after photorefractive keratectomy. [2007.07]
Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium. [2006.06]
[Eyelid contact allergic eczema caused by topical ketorolac tromethamine 0.5%] [2006.04]
Pain associated with carotid artery surgery performed under carotid plexus block: preemptive analgesic effect of ketorolac. [2006.03]
Corneal ulceration and perforation with ketorolac tromethamine (Acular) use after PRK. [2006.02]
An update on the use of ophthalmic ketorolac tromethamine 0.4%. [2006.01]
Non-steroidal anti-inflammatory agents for cystoid macular oedema following cataract surgery: a systematic review. [2005.11]
Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery. [2005.01.25]
Other possibly related research studies
Ocular permeation and inhibition of retinal inflammation: an examination of data and expert opinion on the clinical utility of nepafenac. [2006.02]
Three cases of corneal melting after instillation of a new nonsteroidal anti-inflammatory drug. [2006.02]
Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis. [2005]
Effects of topical anti-inflammatory agents in a botulinum toxin B-induced mouse model of keratoconjunctivitis sicca. [2007.02]
Nepafenac-associated corneal melt. [2007.11]
Effects of nonsteroidal ophthalmic drops on epithelial healing and pain in patients undergoing bilateral photorefractive keratectomy (PRK). [2007.11]
Comparison between two cyclooxygenase inhibitors in an experimental dry eye model in albino rabbits. [2008.06]
Comparison of topical lignocaine gel and fentanyl for perioperative analgesia in children undergoing cataract surgery. [2008.12.23]
Calotropis procera -induced keratitis. [2009.01]
|
